201 related articles for article (PubMed ID: 27154787)
1. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema.
Sun F; Skolny MN; Swaroop MN; Rawal B; Catalano PJ; Brunelle CL; Miller CL; Taghian AG
Breast Cancer Res Treat; 2016 Jun; 157(2):229-240. PubMed ID: 27154787
[TBL] [Abstract][Full Text] [Related]
2. The impact of breast cancer-related lymphedema on the ability to perform upper extremity activities of daily living.
O'Toole JA; Ferguson CM; Swaroop MN; Horick N; Skolny MN; Brunelle CL; Miller CL; Jammallo LS; Specht MC; Taghian AG
Breast Cancer Res Treat; 2015 Apr; 150(2):381-8. PubMed ID: 25749734
[TBL] [Abstract][Full Text] [Related]
3. A novel, validated method to quantify breast cancer-related lymphedema (BCRL) following bilateral breast surgery.
Miller CL; Specht MC; Horick N; Skolny MN; Jammallo LS; O'Toole J; Taghian AG
Lymphology; 2013 Jun; 46(2):64-74. PubMed ID: 24354105
[TBL] [Abstract][Full Text] [Related]
4. Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema.
Sun F; Hall A; Tighe MP; Brunelle CL; Sayegh HE; Gillespie TC; Daniell KM; Taghian AG
Breast Cancer Res Treat; 2018 Nov; 172(1):83-91. PubMed ID: 30062571
[TBL] [Abstract][Full Text] [Related]
5. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?
Specht MC; Miller CL; Russell TA; Horick N; Skolny MN; O'Toole JA; Jammallo LS; Niemierko A; Sadek BT; Shenouda MN; Finkelstein DM; Smith BL; Taghian AG
Breast Cancer Res Treat; 2013 Aug; 140(3):485-94. PubMed ID: 23912961
[TBL] [Abstract][Full Text] [Related]
6. Comparison of perometry-based volumetric arm measurements and bioimpedance spectroscopy for early identification of lymphedema in a prospectively-screened cohort of breast cancer patients.
Gillespie TC; Roberts SA; Brunelle CL; Bucci LK; Bernstein MC; Daniell KM; Naoum GN; Miller CL; Taghian AG
Lymphology; 2021; 54(1):1-11. PubMed ID: 34506083
[TBL] [Abstract][Full Text] [Related]
7. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
8. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.
Sagen A; Kaaresen R; Sandvik L; Thune I; Risberg MA
Arch Phys Med Rehabil; 2014 May; 95(5):875-81. PubMed ID: 24389401
[TBL] [Abstract][Full Text] [Related]
9. Methods for quantifying breast cancer-related lymphedema in patients undergoing a contralateral prophylactic mastectomy.
Roberts SA; Brunelle CL; Gillespie TC; Shui AM; Daniell KM; Lavoie MW; Naoum GE; Taghian AG
Lymphology; 2021; 54(3):113-121. PubMed ID: 34929072
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
11. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
12. Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort.
Brunelle CL; Roberts SA; Shui AM; Gillespie TC; Daniell KM; Naoum GE; Taghian A
J Surg Oncol; 2020 Aug; 122(2):155-163. PubMed ID: 32497273
[TBL] [Abstract][Full Text] [Related]
13. Lymph node status and breast cancer-related lymphedema.
Purushotham AD; Bennett Britton TM; Klevesath MB; Chou P; Agbaje OF; Duffy SW
Ann Surg; 2007 Jul; 246(1):42-5. PubMed ID: 17592289
[TBL] [Abstract][Full Text] [Related]
14. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
[TBL] [Abstract][Full Text] [Related]
15. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
16. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors.
Fu MR; Chen CM; Haber J; Guth AA; Axelrod D
Ann Surg Oncol; 2010 Jul; 17(7):1847-53. PubMed ID: 20140528
[TBL] [Abstract][Full Text] [Related]
17. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
18. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.
Swaroop MN; Ferguson CM; Horick NK; Skolny MN; Miller CL; Jammallo LS; Brunelle CL; O'Toole JA; Isakoff SJ; Specht MC; Taghian AG
Breast Cancer Res Treat; 2015 Jun; 151(2):393-403. PubMed ID: 25940996
[TBL] [Abstract][Full Text] [Related]
19. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
